| Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy C Karacin, T Eren, E Zeynelgil, GI Imamoglu, M Altinbas, I Karadag, ... Future Oncology 17 (33), 4447-4456, 2021 | 41 | 2021 |
| The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer HA Yasar, K Bir Yucel, C Arslan, G Ucar, S Karakaya, B Bilgin, H Taban, ... Journal of Oncology Pharmacy Practice 26 (5), 1110-1116, 2020 | 27 | 2020 |
| Comparison of HER2-zero and HER2-low in terms of clinicopathological factors and survival in early-stage breast cancer: A systematic review and meta-analysis Y Ergun, G Ucar, B Akagunduz Cancer treatment reviews 115, 102538, 2023 | 24 | 2023 |
| Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients T Eren, C Karacin, G Ucar, Y Ergun, O Yazici, Gİ İmamoglu, N Ozdemir Medicine 99 (22), e20346, 2020 | 21 | 2020 |
| Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer G Ucar, Y Ergun, SA Esen, Y Acikgoz, M Dirikoc, İ Esen, Ö Bal, D Uncu Medicine 99 (39), e22407, 2020 | 20 | 2020 |
| The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer G Ucar, Y Ergun, Y Acikgoz, D Uncu Asia‐Pacific Journal of Clinical Oncology 16 (5), e179-e184, 2020 | 19 | 2020 |
| Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study Y Ergun, NY Ozdemir, S Toptas, A Kurtipek, T Eren, O Yazici, ... J BUON 24 (4), 1719-1726, 2019 | 17 | 2019 |
| Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer? Y Ergun, O Bal, M Dogan, G Ucar, M Dirikoc, Y Acikgoz, F Bacaksiz, ... Journal of Research in Medical Sciences 25 (1), 14, 2020 | 14 | 2020 |
| The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors KB Yücel, E Yekedüz, S Karakaya, D Tural, İ Ertürk, C Erol, Ö Ercelep, ... Scientific reports 12 (1), 16559, 2022 | 13 | 2022 |
| Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study) M Hizal, MAN Sendur, HA Yasar, K Bir Yucel, C Arslan, G Ucar, ... Journal of Oncology Pharmacy Practice 26 (7), 1583-1589, 2020 | 11 | 2020 |
| KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer Y Ergun, Y Acikgoz, O Bal, G Ucar, M Dirikoc, E Caliskan Yildirim, ... Expert Review of Molecular Diagnostics 19 (12), 1131-1140, 2019 | 9 | 2019 |
| Anxiety, Insomnia and Pandemic Awareness of Cancer Patients Receiving Chemotherapy During the COVID-19 Pandemic Period. S Akturk Esen, Y Acikgoz, M Yildirim, G Ucar, Y Ergun, M Dirikoc, O Bal, ... UHOD: International Journal of Hematology & Oncology/Uluslararasi Hematoloji …, 2021 | 7 | 2021 |
| Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma? G Ucar, Y Acikgoz, Y Ergun, O Bal, M Yilmaz, S Karakaya, N Akdeniz, ... Cureus 12 (9), 2020 | 7 | 2020 |
| The effect of chemotherapy on olfactory function and mucociliary clearance FC Eravcı, G Uçar, KM Özcan, M Çolak, Y Ergün, Y Açıkgöz, ... Supportive Care in Cancer 29, 1635-1641, 2021 | 6 | 2021 |
| Gastric cancer patients with bone marrow metastasis: a single-center experience and review of the literature Y Ergun, D Uncu, O Yazici, G Ucar, EK Karabuga, N Zengin Eurasian J Med Oncol 1, 160-3, 2017 | 5 | 2017 |
| Predictive and prognostic effect of ABO blood group on immune checkpoint inhibitors Y Ergun, SA Esen, M Bardakci, G Ucar, Z Kalkan, Z Urakci, E Seyran, ... Cancer Biomarkers 34 (2), 329-336, 2022 | 4 | 2022 |
| Is it safe to use long-acting G-CSF for febrile neutropenia prophylaxis in COVID-19 pandemic? Y Ergun, SA Esen, G Ucar, Y Acikgoz, C Karacin JCO oncology practice 17 (7), 455-456, 2021 | 4 | 2021 |
| The comparison of mDCF and mFOLFOX-6 as first-line treatment in metastatic gastric cancer Y Acikgoz, SA Esen, G Ucar, M Dirikoc, Y Ergun, O Bal, D Uncu Cureus 13 (5), 2021 | 4 | 2021 |
| One-Pot Access to 2-Aryl-3-(Arylmethyl) Chromones MY Chang, KT Chen, YL Tsai, HY Chen Synthesis 52 (06), 861-872, 2020 | 4 | 2020 |
| Efficacy of the combination of modified docetaxel, cisplatin and fluorouracil in locally advanced gastric cancer: Evaluation of real-life outcomes E Tulay, C KARACIN, U Gokhan, Y ERGUN, O YAZICI, GI IMAMOGLU, ... International Journal of Hematology and Oncology 33 (4), 023-031, 2020 | 4 | 2020 |
